Functional and Transcriptomic Characterization of Peritoneal Immune-Modulation by Addition of Alanyl-Glutamine to Dialysis Fluid
Abstract Peritonitis remains a major cause of morbidity and mortality during chronic peritoneal dialysis (PD). Glucose-based PD fluids reduce immunological defenses in the peritoneal cavity. Low concentrations of peritoneal extracellular glutamine during PD may contribute to this immune deficit. For...
Guardado en:
Autores principales: | Rebecca Herzog, Lilian Kuster, Julia Becker, Tobias Gluexam, Dietmar Pils, Andreas Spittler, Manoj K. Bhasin, Seth L. Alper, Andreas Vychytil, Christoph Aufricht, Klaus Kratochwill |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9cfa7994a28245e394ea579d9e00800f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients – the Vienna Cohort
por: Georg Beilhack, et al.
Publicado: (2021) -
Continuous ambulatory peritoneal dialysis peritonitis guidelines – Consensus statement of peritoneal dialysis society of India - 2020
por: Tarun K Jeloka, et al.
Publicado: (2021) -
Brevundimonas vesicularis Peritonitis in a Chronic Peritoneal Dialysis Patient
por: Vijayakumar Paramasivam, et al.
Publicado: (2021) -
Foley catheter used for peritoneal dialysis
por: Mujaheed Suleman, et al.
Publicado: (2021) -
Hypoglycemic therapy in patients on hemodialysis and peritoneal dialysis
por: Irina Arkad'evna Bondar', et al.
Publicado: (2010)